ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

January 22, 1999

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992

Shubik applauded for NCAB Service

February 12, 1982

NCI Plans to Fund FY 1985 R01s, P01s with Cuts 2.9-3.8% Under Recommended Groups, Centers Reduced 7-10%

March 16, 1984

Peters Replaced As Director Of Karmanos Cancer Center.

December 1, 2000

Under Ultimatum, NIH Databases Remove “Misconduct” Tags From Papers By Fisher

February 24, 1995